In particular, in PCOS, which is frequently associated with endometriosis, the use of SP has been proposed not only as an anti-androgen, but also as an anti-MR, to reduce the side effects related to the activation of the renin-angiotensin-aldosterone system, represented by increased ARR [14,35,36]. Here, NR3C2 is linked to polycystic ovary syndrome.